Neoleukin Therapeutics, Inc. (NLTX) Stock Analysis
DELISTED 2023
What happened to Neoleukin Therapeutics, Inc. (NLTX) stock?
Neoleukin Therapeutics, Inc. (NLTX) no longer trades on public markets. It was delisted in December 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- December 2023
- Last recorded price (historical):
- $3.49 (last quote on record before the December 2023 delisting; historical, not a current quote)
Market cap $8.20M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Neoleukin Therapeutics, Inc. (NLTX). Neoleukin Therapeutics, Inc. is a biopharmaceutical company specializing in the development of immunotherapies using protein design technology. Their lead product candidate, NL-201, aims to treat various cancers by mimicking interleukin cytokines.
Last analyzed: May 10, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Neoleukin Therapeutics, Inc. (NLTX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy NLTX shares?
No. NLTX stopped trading on public markets in December 2023, so the shares are not available through a broker. Anything you see quoted for NLTX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before NLTX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Neoleukin Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.